BIDOLI PAOLO

Ruolo: 
Professore associato
Settore scientifico disciplinare: 
ONCOLOGIA MEDICA (MED/06)

Pubblicazioni

  • Cavaletti, G., Cornblath, D., Merkies, I., Postma, T., Rossi, E., Alberti, P., et al. (2019). Patients' and physicians' interpretation of chemotherapy-induced peripheral neurotoxicity. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 24(1), 111-119. Dettaglio
  • Sharma, G., Cortinovis, D., Agustoni, F., Arosio, G., Villa, M., Cordani, N., et al. (2019). A Compound L1196M/G1202R ALK Mutation in a Patient with ALK-Positive Lung Cancer with Acquired Resistance to Brigatinib Also Confers Primary Resistance to Lorlatinib. JOURNAL OF THORACIC ONCOLOGY, 14(11), e257-e259. Dettaglio
  • Crinò, L., Bidoli, P., Delmonte, A., Grossi, F., De Marinis, F., Ardizzoni, A., et al. (2019). Italian Cohort of Nivolumab Expanded Access Program in Squamous Non-Small Cell Lung Cancer: Results from a Real-World Population. THE ONCOLOGIST, 24(11), e1165-e1171. Dettaglio
  • Esposito Abate, R., Pasquale, R., Sacco, A., Piccirillo, M., Morabito, A., Bidoli, P., et al. (2019). Liquid Biopsy Testing Can Improve Selection of Advanced Non-Small-Cell Lung Cancer Patients to Rechallenge with Gefitinib. CANCERS, 11(10). Dettaglio
  • Abbate, M., Cortinovis, D., Tiseo, M., Vavalà, T., Cerea, G., Toschi, L., et al. (2019). Peritoneal carcinomatosis in non-small-cell lung cancer: retrospective multicentric analysis and literature review. FUTURE ONCOLOGY, 15(9), 989-994. Dettaglio